TPVB or SPSIPB in Pain Management After VATS

Launched by KOÇ UNIVERSITY · May 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for patients undergoing a type of surgery called video-assisted thoracoscopic surgery (VATS). The researchers want to find out which method—thoracal paravertebral block (TPVB) or serratus posterior superior intercostal plane block (SPSIPB)—is more effective in reducing pain after surgery and how much pain medication (opioids) patients need in the first 24 hours following their operation. By comparing the experiences of two groups of patients, one receiving TPVB and the other receiving SPSIPB, the trial aims to see which method leads to less pain and fewer side effects from opioids.

To participate in this study, individuals must be between 18 and 80 years old and scheduled for VATS. However, people with certain conditions, such as allergies to local anesthetics, chronic opioid use, or psychiatric disorders, may not be eligible. If you join the trial, you can expect to receive one of the two pain management techniques before your surgery and will be monitored afterward for your pain levels and any side effects. This research is important because it could help improve pain management after VATS and reduce the need for strong pain medications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients between the age of 18-80 undergoing video-assisted thoracoscopic surgery
• Exclusion Criteria:
• • Allergy to local anaesthetics Chronic opioid use history Patients with psychiatric disorders Patients who are not open to communication Patients with chronic organ failure Patients that do not give consent Patients that need emergency surgery within the first 24 hours of the initial surgery

Trial Officials